MD, PhD, MBA
Dr. David Greene, MD, PhD, MBA, stands at the forefront of regenerative medicine and healthcare innovation, blending clinical expertise with entrepreneurial vision. As the founder and CEO of R3 Stem Cell and US Lead Network, Dr. Greene has dedicated his career to advancing patient care and empowering medical practices through advanced therapies and digital marketing excellence.
A residency and fellowship-trained orthopedic surgeon, Dr. Greene began his journey in medicine with a deep commitment to helping others. After years in clinical practice, he recognized the transformative potential of regenerative therapies and the urgent need for better patient access and education. This insight led him to establish R3 Stem Cell, now a global leader in non-surgical treatment options using stem cell and PRP therapy. Under his leadership, R3 Stem Cell has performed over 26,000 procedures across more than 45 international clinics, offering hope and healing to patients worldwide.
Dr. Greene’s entrepreneurial spirit didn’t stop at clinical innovation. He also founded US Lead Network, a healthcare internet marketing company that leverages artificial intelligence to help medical and dental practices grow their patient base efficiently and ethically. His two books on healthcare internet marketing have become essential reading for providers seeking to navigate the complexities of digital patient acquisition. Recognized as a Top 20 Expert Author by Ezines.com – ranking #15 out of over 470,000 authors and #1 in Pain Management – Dr. Greene’s thought leadership has shaped the way healthcare professionals connect with patients online.
A defining moment in Dr. Greene’s career was his decision to leave clinical practice and focus entirely on innovation and education. “I’ve never been a fan of just settling for the status quo. Innovation is a cornerstone of what makes America great,” he reflects. This philosophy has driven R3 Stem Cell’s mission to provide affordable, high-quality regenerative care and to demystify stem cell therapies through comprehensive training courses and educational content for both providers and patients.
Dr. Greene’s work has garnered international recognition, including a feature on the cover of Corporate Vision magazine, where his commitment to affordable, accessible regenerative therapies was spotlighted. His impact extends beyond business metrics – he is known for his compassionate approach, always prioritizing patient education and ethical practice.
Outside of his professional life, Dr. Greene is inspired by the words of Maya Angelou: “My mission in life is not merely to survive, but to thrive; and to do so with some passion, some compassion, some humor, and some style”. He brings this ethos to his daily work, fostering a culture of innovation, empathy, and continuous learning.
When he’s not leading global healthcare initiatives, Dr. Greene enjoys sharing insights on social media, connecting with colleagues, and pursuing personal interests that keep him grounded and inspired.
Dr. David Greene’s journey is a testament to the power of combining clinical skill, business acumen, and a heartfelt commitment to making a difference – one patient, one practice, and one innovation at a time.
All Posts
Professional fighters place extraordinary, repetitive stress on their joints and connective tissue over the course of a career. Chronic knee pain and forearm or elbow overuse injuries often become the deciding factor in how long an athlete can keep competing. That reality has fueled growing
For patients managing multiple chronic illnesses simultaneously, finding an effective path forward can feel overwhelming. When conditions like Sjögren’s syndrome, Lyme disease, and Rocky Mountain spotted fever overlap, the symptom burden — particularly persistent fatigue and cognitive impairment — can significantly diminish quality of life.
iPSCs generate more excitement — and more complex challenges — than almost any other stem cell type being studied today. For patients exploring regenerative medicine, understanding what it is, why it matters, and why it remains unavailable as a treatment is essential. https://www.youtube.com/watch?v=ogcWej42MQ8 What Does
For patients with advanced chronic kidney disease (CKD), stem cell therapy is an increasingly researched option. A key practical question: does delivery method matter — IV infusion or direct renal artery injection? https://www.youtube.com/watch?v=iobIojC4lmk IV Infusion vs. Renal Artery Injection IV Infusion Stem cells enter the
If you are considering a stem cell procedure, one of the most important questions you can ask is: How can I be sure the donor tissue is safe? The answer involves a federally regulated, multi-step process that begins long before any product reaches a clinic.
If you’re researching stem cell therapy, one question comes up quickly: what actually happens inside my body after treatment? The answer has changed significantly over the past decade. Earlier assumptions have been revised, and scientists now recognize multiple distinct pathways through which stem cell therapies
When Standard Migraine Treatments Are No Longer Enough For many migraine sufferers, the journey through treatment is long and frustrating. Triptans, beta-blockers, antiepileptics, CGRP inhibitors, and botulinum toxin injections each work well for some patients — but not for everyone. A meaningful subset of patients
Chronic low back pain doesn’t just hurt. It takes over your life. It disrupts sleep, limits movement, affects appetite, and, for many patients, leads to long-term dependence on powerful opioid medications. When nothing else works, many people feel like they’ve run out of options. Veronica
For decades, neurologists have told stroke survivors that meaningful recovery is largely limited to the first two years after the event. Once that window closes, patients are advised to adapt — learning compensatory strategies like using the non-dominant hand or relying on assistive devices for
In the rapidly evolving world of regenerative medicine, patients are moving away from temporary fixes like steroid injections and toward therapies that actually repair tissue. Two of the most popular non-surgical treatments leading this charge are Platelet-Rich Plasma (PRP) and Exosome therapy. While both utilize
